Corvus Pharmaceuticals, Inc. (CRVS) Price History & Returns
How Corvus Pharmaceuticals, Inc. (CRVS) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $10.53 sits 20% of the way up a 52-week range of $6.39 to $26.95; 60.9% below the 52-week high; a beta of 0.86 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
5 of 10 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 23 of 36 months closed higher than the month before. Each figure is the last close in that month.
Corvus Pharmaceuticals, Inc. (CRVS) price history — frequently asked questions
How has Corvus Pharmaceuticals, Inc. performed over the last year?
Corvus Pharmaceuticals, Inc. (CRVS) has risen 192.9% over the last twelve months, measured on price alone.
What is Corvus Pharmaceuticals, Inc.'s five-year return?
Over five years the CRVS share price has gained 542.5%, excluding dividends.
What is Corvus Pharmaceuticals, Inc.'s 52-week range?
Over the last year Corvus Pharmaceuticals, Inc. (CRVS) has traded between $6.39 and $26.95.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.